{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:55:58Z","timestamp":1776869758287,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK (GB)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13048-015-0189-4","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T12:38:10Z","timestamp":1442579890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cucurbit [7] uril encapsulated cisplatin overcomes resistance to cisplatin induced by Rab25 overexpression in an intraperitoneal ovarian cancer model"],"prefix":"10.1186","volume":"8","author":[{"given":"Natividad","family":"Gomez-Roman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nial J.","family":"Wheate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Plumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"issue":"4","key":"189_CR1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/cncr.23601","volume":"113","author":"T Pal","year":"2008","unstructured":"Pal T, Permuth-Wey J, Sellers TA. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer. 2008;113(4):733\u201342. doi: 10.1002\/Cncr.23601 .","journal-title":"Cancer"},{"key":"189_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/ijgc-00009577-199609001-00006","volume":"6","author":"DS Alberts","year":"1996","unstructured":"Alberts DS, Liu PY, Hannigan EV, OToole R, Williams SD, Young JA, et al. Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup study. Int J Gynecol Cancer. 1996;6:28\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"189_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/annonc\/mdq377","volume":"21","author":"JA Ledermann","year":"2010","unstructured":"Ledermann JA, Kristeleit RS. Optimal treatment for relapsing ovarian cancer. Ann Oncol. 2010;21:218\u201322. doi: 10.1093\/annonc\/mdq377 .","journal-title":"Ann Oncol"},{"key":"189_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/annonc\/mdq368","volume":"21","author":"MA Bookman","year":"2010","unstructured":"Bookman MA. The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer. Ann Oncol. 2010;21:211\u20137. doi: 10.1093\/annonc\/mdq368 .","journal-title":"Ann Oncol"},{"issue":"9375","key":"189_CR5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","volume":"361","author":"MKB Parmar","year":"2003","unstructured":"Parmar MKB, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial. Lancet. 2003;361(9375):2099\u2013106.","journal-title":"Lancet"},{"issue":"6","key":"189_CR6","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/JCO.2005.05.2456","volume":"24","author":"M Markman","year":"2006","unstructured":"Markman M, Walker JL. Intraperitoneal chemotherapy of ovarian cancer: A review, with a focus on practical aspects of treatment. J Clin Oncol. 2006;24(6):988\u201394. doi: 10.1200\/Jco.2005.05.2456 .","journal-title":"J Clin Oncol"},{"issue":"1","key":"189_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2010.06.003","volume":"119","author":"JO Schorge","year":"2010","unstructured":"Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR, et al. SGO white paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol. 2010;119(1):7\u201317. doi: 10.1016\/j.ygyno.2010.06.003 .","journal-title":"Gynecol Oncol"},{"issue":"6","key":"189_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000313823","volume":"33","author":"MC Lim","year":"2010","unstructured":"Lim MC, Song YJ, Seo SS, Yoo CW, Kang S, Park SY. Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer. Onkologie. 2010;33(6):324\u201330. doi: 10.1159\/000313823 .","journal-title":"Onkologie"},{"issue":"11","key":"189_CR9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1054\/bjoc.2000.1487","volume":"83","author":"KA Scott","year":"2000","unstructured":"Scott KA, Holdsworth H, Balkwill FR, Dias S. Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model. Brit J Cancer. 2000;83(11):1538\u201343.","journal-title":"Brit J Cancer"},{"key":"189_CR10","doi-asserted-by":"crossref","unstructured":"Al-Niaimi A, Manuelli B, Safdar N, Chappell R, Seo S, Kushner D et al. Survival with surgical versus medical treatment of patients with bowel obstruction secondary to ovarian cancer recurrence: A 15-year experience. J Clin Oncol. 2009;27(15).","DOI":"10.1111\/j.1365-2753.2008.01016.x"},{"key":"189_CR11","doi-asserted-by":"crossref","first-page":"14 2 1","DOI":"10.1002\/0471141755.ph1412s45","volume":"45","author":"DC Connolly","year":"2009","unstructured":"Connolly DC, Hensley HH. Xenograft and transgenic mouse models of epithelial ovarian cancer and Non invasive imaging modalities to monitor ovarian tumor growth in situ -applications in evaluating novel therapeutic agents. Curr Protoc Pharmacol. 2009;45:14 2 1\u20132 26.","journal-title":"Curr Protoc Pharmacol"},{"key":"189_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7827-1-67","volume":"1","author":"BC Vanderhyden","year":"2003","unstructured":"Vanderhyden BC, Shaw TJ, Ethier JF. Animal models of ovarian cancer. Reprod Biol Endocrinol. 2003;1:67. doi: 10.1186\/1477-7827-1-67 .","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"189_CR13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4161\/cbt.6.11.4830","volume":"6","author":"H Hensley","year":"2007","unstructured":"Hensley H, Quinn BA, Wolf RL, Litwin SL, Mabuchi S, Williams SJ, et al. Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer Biol Ther. 2007;6(11):1717\u201325.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"189_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nm1173","volume":"11","author":"DM Dinulescu","year":"2005","unstructured":"Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005;11(1):63\u201370. doi: 10.1038\/Nm1173 .","journal-title":"Nat Med"},{"key":"189_CR15","doi-asserted-by":"crossref","unstructured":"Ingersoll SB, Yue P, Ahmad S, Turkson J, Edwards JR, Holloway RW. Molecular characterization of highly tumorigenic cell lines used in a xenograph model to investigate cellular therapy for the treatment of refractory ovarian cancer. J Clin Oncol. 2009;27(15).","DOI":"10.1200\/jco.2009.27.15_suppl.e16516"},{"issue":"11","key":"189_CR16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/nm1125","volume":"10","author":"KW Cheng","year":"2004","unstructured":"Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med. 2004;10(11):1251\u20136. doi: 10.1038\/Nm1125 .","journal-title":"Nat Med"},{"issue":"2","key":"189_CR17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI112335","volume":"77","author":"E Reed","year":"1986","unstructured":"Reed E, Yuspa SH, Zwelling LA, Ozols RF, Poirier MC. Quantitation of Cis-Diamminedichloroplatinum-Ii (Cisplatin)-DNA-intrastrand adducts in testicular and ovarian-cancer patients receiving cisplatin chemotherapy. J Clin Invest. 1986;77(2):545\u201350.","journal-title":"J Clin Invest"},{"issue":"25","key":"189_CR18","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1021\/jo051655r","volume":"70","author":"J Lagona","year":"2005","unstructured":"Lagona J, Fettinger JC, Isaacs L. Cucurbit[n]uril analogues: synthetic and mechanistic studies. J Org Chem. 2005;70(25):10381\u201392. doi: 10.1021\/Jo0516655r .","journal-title":"J Org Chem"},{"issue":"3","key":"189_CR19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/ja993376p","volume":"122","author":"J Kim","year":"2000","unstructured":"Kim J, Jung IS, Kim SY, Lee E, Kang JK, Sakamoto S, et al. New cucurbituril homologues: syntheses, isolation, characterization, and X-ray crystal structures of cucurbit[n]uril (n\u2009=\u20095, 7, and 8). J Am Chem Soc. 2000;122(3):540\u20131.","journal-title":"J Am Chem Soc"},{"issue":"39","key":"189_CR20","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1002\/anie.200702540","volume":"46","author":"J Kim","year":"2007","unstructured":"Kim J, Ahn Y, Park KM, Kim Y, Ko YH, Oh DH, et al. Carbohydrate wheels: cucurbituril-based carbohydrate clusters. Angew Chem Int Ed Engl. 2007;46(39):7393\u20135. doi: 10.1002\/anie.200702540 .","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"189_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1039\/c2mt20054f","volume":"4","author":"JA Plumb","year":"2012","unstructured":"Plumb JA, Venugopal B, Oun R, Gomez-Roman N, Kawazoe Y, Venkataramanan NS, et al. Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect. Metallomics. 2012;4(6):561\u20137. doi: 10.1039\/c2mt20054f .","journal-title":"Metallomics"},{"issue":"2","key":"189_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nprot.2007.25","volume":"2","author":"CL Morton","year":"2007","unstructured":"Morton CL, Houghton PJ. Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc. 2007;2(2):247\u201350.","journal-title":"Nat Protoc"},{"key":"189_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2342-8-16","volume":"8","author":"MM Jensen","year":"2008","unstructured":"Jensen MM, Jorgensen JT, Binderup T, Kjaer A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18\u00a0F-FDG-microPET or external caliper. BMC Med Imaging. 2008;8:16.","journal-title":"BMC Med Imaging"},{"issue":"11","key":"189_CR24","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1464-410X.2010.09424.x","volume":"106","author":"PC Black","year":"2010","unstructured":"Black PC, Shetty A, Brown GA, Esparza-Coss E, Metwalli AR, Agarwal PK, et al. Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis. BJU Int. 2010;106(11):1799\u2013804.","journal-title":"BJU Int"},{"issue":"5","key":"189_CR25","first-page":"902","volume":"7","author":"JA Plumb","year":"1987","unstructured":"Plumb JA, Milroy R, Kaye SB. Optimization of a chemosensitivity assay based on reduction of the tetrazolium Dye, Mtt. Anticancer Res. 1987;7(5):902.","journal-title":"Anticancer Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0189-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T06:13:02Z","timestamp":1718086382000},"score":1,"resource":{"primary":{"URL":"http:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-015-0189-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1186\/s13048-015-0189-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]},"article-number":"62"}}